The -174G/C Interleukin-6 Gene Promoter Polymorphism as a Genetic Marker of Differences in Therapeutic Response to Methotrexate and Leflunomide in Rheumatoid Arthritis

por Ruiz-Padilla, A. J., Gamez-Nava, J. I., Saldaña-Cruz, A. M., Murillo-Vazquez, J. D., Vazquez-Villegas, M. L., Zavaleta-Muñiz, S. A., Martín-Márquez, B. T., Ponce-Guarneros, J. M., Rodriguez Jimenez, N. A., Flores-Chavez, A., Sandoval-Garcia, F., Vasquez-Jimenez, J. C., Cardona-Muñoz, E. G., Totsuka-Sutto, S. E., Gonzalez-Lopez, L.
Publicado 2016